Clinical Trials | Worldwide Clinical Trials

Five Signs Your Clinical Trial Might Need A Rescue

By The Editors of Uncommon Conversations, August 25, 2020

The following blog is a discussion of clinical trial pain points that may indicate a need for rescue study intervention.

It’s Still All About Relationships: Why Sponsors, CROs, Patients, and Study Sites Are Key to Improving Performance

By Jeff Zucker, M.S., Senior Vice President, Clinical Operations and Trial Optimization, August 18, 2020

Throughout the clinical trial industry, stakeholders are embracing the value of patient centricity in the execution of drug development research and in understanding real-world marketability. Recognizing the role of sites and investigators in supporting patient-focused studies, Jeff Zucker identifies six areas in which CROs might nurture site relations.

COVID-Era Phase I Clinical Pharmacology Studies Don’t Have to Be Daunting

By The Editors at Uncommon Conversations, August 13, 2020

Times have changed. It’s no longer sufficient to have a promising new drug to test and a relationship with an academic research hospital to get your study off the ground. You need a state-of-the-art Phase I unit with enhanced precautions to ensure the efficacy of your study and safety of patients.